{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T18:02:30Z","timestamp":1789668150679,"version":"4.0.1"},"reference-count":83,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T00:00:00Z","timestamp":1789603200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T00:00:00Z","timestamp":1789603200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Med Chem Res"],"DOI":"10.1007\/s00044-026-03616-4","type":"journal-article","created":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T12:27:17Z","timestamp":1789648037000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Artificial intelligence\u2013assisted lead optimization in drug discovery: bridging computational advances and translational challenges"],"prefix":"10.1007","author":[{"given":"Fatma AlZahraa A. A.","family":"Mohamed","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-5034-1495","authenticated-orcid":false,"given":"Ahmed Mohsen Kamal","family":"El-sagheir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,17]]},"reference":[{"issue":"2","key":"3616_CR1","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1038\/nrd.2017.232","volume":"17","author":"G Schneider","year":"2018","unstructured":"Schneider G. Automating drug discovery. Nat Rev Drug Discov. 2018;17(2):97\u2013113.","journal-title":"Nat Rev Drug Discov"},{"issue":"1","key":"3616_CR2","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.drudis.2020.10.010","volume":"26","author":"D Paul","year":"2021","unstructured":"Paul D, Sanap G, Shenoy S, et al. Artificial intelligence in drug discovery and development. Drug Discov Today. 2021;26(1):80\u201393.","journal-title":"Drug Discov Today"},{"key":"3616_CR3","doi-asserted-by":"publisher","first-page":"2694","DOI":"10.3762\/bjoc.12.267","volume":"12","author":"SP Leelananda","year":"2016","unstructured":"Leelananda SP, Lindert S. Computational methods in drug discovery. Beilstein J Org Chem. 2016;12:2694\u2013718.","journal-title":"Beilstein J Org Chem"},{"issue":"12","key":"3616_CR4","doi-asserted-by":"publisher","first-page":"4977","DOI":"10.1021\/jm4004285","volume":"57","author":"A Cherkasov","year":"2014","unstructured":"Cherkasov A, Muratov EN, Fourches D, et al. QSAR modeling: Where have you been? where are you going to? J Med Chem. 2014;57(12):4977\u20135010.","journal-title":"J Med Chem"},{"key":"3616_CR5","doi-asserted-by":"publisher","first-page":"65","DOI":"10.3389\/fbioe.2019.00065","volume":"7","author":"Y Matsuzaka","year":"2019","unstructured":"Matsuzaka Y, Uesawa Y. Optimization of a deep-learning method based on the classification of images generated by parameterized deep snap a novel molecular-image-input technique for quantitative structure-activity relationship (QSAR) analysis. Front Bioeng Biotechnol. 2019;7:65.","journal-title":"Front Bioeng Biotechnol"},{"issue":"7553","key":"3616_CR6","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1038\/nature14539","volume":"521","author":"Y LeCun","year":"2015","unstructured":"LeCun Y, Bengio Y. Hinton. Deep learning. Nature. 2015;521(7553):436\u201344.","journal-title":"Nature"},{"issue":"1","key":"3616_CR7","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1002\/minf.201501008","volume":"35","author":"E Gawehn","year":"2016","unstructured":"Gawehn E, Hiss JA, Schneider G. Deep learning in drug discovery. Mol Inf. 2016;35(1):3\u201314.","journal-title":"Mol Inf"},{"key":"3616_CR8","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.ymeth.2020.05.009","volume":"179","author":"J Jo","year":"2020","unstructured":"Jo J, Kwak B, Choi HS, et al. The message passing neural networks for chemical property prediction on SMILES. Methods. 2020;179:65\u201372.","journal-title":"Methods"},{"issue":"2","key":"3616_CR9","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1021\/acscentsci.7b00572","volume":"4","author":"R G\u00f3mez-Bombarelli","year":"2018","unstructured":"G\u00f3mez-Bombarelli R, Wei JN, Duvenaud D, et al. Automatic chemical design using a data-driven continuous representation of molecules. ACS Cent Sci. 2018;4(2):268\u201376.","journal-title":"ACS Cent Sci"},{"key":"3616_CR10","doi-asserted-by":"publisher","first-page":"1256","DOI":"10.1038\/s42256-022-00580-7","volume":"4","author":"J Ross","year":"2022","unstructured":"Ross J, Belgodere B, Chenthamarakshan V, et al. Large-scale chemical language representations capture molecular structure and properties. Nat Mach Intell. 2022;4:1256\u201364.","journal-title":"Nat Mach Intell"},{"issue":"9","key":"3616_CR11","doi-asserted-by":"publisher","first-page":"2064","DOI":"10.1021\/acs.jcim.1c00600","volume":"62","author":"V Bagal","year":"2022","unstructured":"Bagal V, Aggarwal R, Vinod PK, et al. MolGPT: Molecular generation using a transformer-decoder model. J Chem Inf Model. 2022;62(9):2064\u201376.","journal-title":"J Chem Inf Model"},{"issue":"7873","key":"3616_CR12","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1038\/s41586-021-03819-2","volume":"596","author":"J Jumper","year":"2021","unstructured":"Jumper J, Evans R, Pritzel A, et al. Highly accurate protein structure prediction with AlphaFold. Nature. 2021;596(7873):583\u20139.","journal-title":"Nature"},{"issue":"19","key":"3616_CR13","doi-asserted-by":"publisher","first-page":"7238","DOI":"10.1021\/acs.jcim.4c01107","volume":"64","author":"A Alakhdar","year":"2024","unstructured":"Alakhdar A, P\u00f3czos B, Washburn N. Diffusion models in de novo drug design. J Chem Inf Model. 2024;64(19):7238\u201356.","journal-title":"J Chem Inf Model"},{"issue":"24","key":"3616_CR14","doi-asserted-by":"publisher","first-page":"5441","DOI":"10.1039\/C8SC00148K","volume":"9","author":"A Mayr","year":"2018","unstructured":"Mayr A, Klambauer G, Unterthiner T, et al. Large-scale comparison of machine learning methods for drug target prediction on ChEMBL. Chem Sci. 2018;9(24):5441\u201351.","journal-title":"Chem Sci"},{"issue":"9","key":"3616_CR15","doi-asserted-by":"publisher","first-page":"1572","DOI":"10.1021\/acscentsci.9b00576","volume":"5","author":"P Schwaller","year":"2019","unstructured":"Schwaller P, Laino T, Gaudin T, et al. Molecular transformer: A model for uncertainty-calibrated chemical reaction prediction. ACS Cent Sci. 2019;5(9):1572\u201383.","journal-title":"ACS Cent Sci"},{"issue":"16","key":"3616_CR16","doi-asserted-by":"publisher","first-page":"8651","DOI":"10.1021\/acs.jmedchem.0c01077","volume":"63","author":"J Bajorath","year":"2020","unstructured":"Bajorath J, Kearnes S, Walters WP, et al. Artificial intelligence in drug discovery: Into the great wide open. J Med Chem. 2020;63(16):8651\u20132.","journal-title":"J Med Chem"},{"issue":"1","key":"3616_CR17","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1038\/nrd.2016.230","volume":"16","author":"R Santos","year":"2017","unstructured":"Santos R, Ursu O, Gaulton A, et al. A comprehensive map of molecular drug targets. Nat Rev Drug Discov. 2017;16(1):19\u201334.","journal-title":"Nat Rev Drug Discov"},{"key":"3616_CR18","doi-asserted-by":"publisher","first-page":"108025","DOI":"10.1016\/j.envint.2023.108025","volume":"177","author":"F Zhang","year":"2023","unstructured":"Zhang F, Wang Z, Peijnenburg WJGM, et al. Machine learning-driven QSAR models for predicting the mixture toxicity of nanoparticles. Environ Int. 2023;177:108025.","journal-title":"Environ Int"},{"issue":"11","key":"3616_CR19","doi-asserted-by":"publisher","first-page":"3525","DOI":"10.1039\/D0CS00098A","volume":"49","author":"EN Muratov","year":"2020","unstructured":"Muratov EN, Bajorath J, Sheridan RP, et al. QSAR without borders. Chem Soc Rev. 2020;49(11):3525\u201364.","journal-title":"Chem Soc Rev"},{"issue":"2","key":"3616_CR20","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1038\/nchem.1243","volume":"4","author":"GR Bickerton","year":"2012","unstructured":"Bickerton GR, Paolini GV, Besnard J, et al. Quantifying the chemical beauty of drugs. Nat Chem. 2012;4(2):90\u20138.","journal-title":"Nat Chem"},{"issue":"9","key":"3616_CR21","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1080\/17460441.2021.1909567","volume":"16","author":"J Jim\u00e9nez-Luna","year":"2021","unstructured":"Jim\u00e9nez-Luna J, Grisoni F, Weskamp N, et al. Artificial intelligence in drug discovery: recent advances and future perspectives. Expert Opin Drug Discov. 2021;16(9):949\u201359.","journal-title":"Expert Opin Drug Discov"},{"issue":"3","key":"3616_CR22","doi-asserted-by":"publisher","first-page":"100240","DOI":"10.1016\/j.dmd.2026.100240","volume":"54","author":"M Malarvannan","year":"2026","unstructured":"Malarvannan M, Monohar S, Kate SS, et al. A review on integrated machine learning and deep learning driven artificial intelligence models for pharmacokinetics and toxicokinetics predictions, and their application. Drug Metab Dispos. 2026;54(3):100240.","journal-title":"Drug Metab Dispos"},{"key":"3616_CR23","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1007\/978-1-0716-1787-8_20","volume":"2390","author":"Z Jia","year":"2022","unstructured":"Jia Z, Gao H. Machine learning for in silico ADMET prediction. Methods Mol Biol. 2022;2390:447\u201360.","journal-title":"Methods Mol Biol"},{"issue":"9","key":"3616_CR24","doi-asserted-by":"publisher","first-page":"5189","DOI":"10.1021\/acs.jcim.6c00535","volume":"66","author":"P Delre","year":"2026","unstructured":"Delre P, Bellofatto G, Lavecchia A. VeGA-RX and VeGA-SCX: Controllable SMARTS-guided generative transformers for precision-driven de novo drug design. J Chem Inf Model. 2026;66(9):5189\u2013205.","journal-title":"J Chem Inf Model"},{"issue":"20","key":"3616_CR25","doi-asserted-by":"publisher","first-page":"10918","DOI":"10.1021\/acs.jcim.5c01606","volume":"65","author":"P Delre","year":"2025","unstructured":"Delre P, Lavecchia A. VeGA: A versatile generative architecture for bioactive molecules across multiple therapeutic targets. J Chem Inf Model. 2025;65(20):10918\u201331.","journal-title":"J Chem Inf Model"},{"issue":"3","key":"3616_CR26","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1038\/s41573-021-00371-6","volume":"21","author":"M B\u00e9k\u00e9s","year":"2022","unstructured":"B\u00e9k\u00e9s M, Langley DR. Crews. PROTAC targeted protein degraders: The past is prologue. Nat Rev Drug Discov. 2022;21(3):181\u2013200.","journal-title":"Nat Rev Drug Discov"},{"issue":"9","key":"3616_CR27","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1038\/s41576-026-00967-x","volume":"27","author":"A Marsico","year":"2026","unstructured":"Marsico A. RNA design across eras: from covariance models to modern generative AI. Nat Rev Genet. 2026;27(9):665.","journal-title":"Nat Rev Genet"},{"issue":"7698","key":"3616_CR28","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1038\/nature25978","volume":"555","author":"MHS Segler","year":"2018","unstructured":"Segler MHS, Preuss M, Waller MP. Planning chemical syntheses with deep neural networks and symbolic AI. Nature. 2018;555(7698):604\u201310.","journal-title":"Nature"},{"issue":"9","key":"3616_CR29","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.1038\/s41587-019-0224-x","volume":"37","author":"A Zhavoronkov","year":"2019","unstructured":"Zhavoronkov A, Ivanenkov YA, Aliper A, et al. Deep learning enables rapid identification of potent DDR1 kinase inhibitors. Nat Biotechnol. 2019;37(9):1038\u201340.","journal-title":"Nat Biotechnol"},{"issue":"5","key":"3616_CR30","doi-asserted-by":"publisher","first-page":"e226","DOI":"10.1016\/S2589-7500(20)30088-1","volume":"2","author":"T Burki","year":"2020","unstructured":"Burki T. A new paradigm for drug development. Lancet Digit Health. 2020;2(5):e226\u20137.","journal-title":"Lancet Digit Health"},{"key":"3616_CR31","doi-asserted-by":"publisher","first-page":"2602","DOI":"10.1038\/s41591-025-03743-2","volume":"31","author":"Z Xu","year":"2025","unstructured":"Xu Z, Ren F, Wang P, et al. A generative AI-discovered TNIK inhibitor for idiopathic pulmonary fibrosis: a randomized phase 2a trial. Nat Med. 2025;31:2602\u201310.","journal-title":"Nat Med"},{"issue":"5","key":"3616_CR32","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1038\/s41563-019-0338-z","volume":"18","author":"S Ekins","year":"2019","unstructured":"Ekins S, Puhl AC, Zorn KM, et al. Exploiting machine learning for end-to-end drug discovery and development. Nat Mater. 2019;18(5):435\u201341.","journal-title":"Nat Mater"},{"issue":"2","key":"3616_CR33","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1038\/s41587-024-02127-0","volume":"42","author":"P Notin","year":"2024","unstructured":"Notin P, Rollins N, Gal Y, et al. Machine learning for functional protein design. Nat Biotechnol. 2024;42(2):216\u201328.","journal-title":"Nat Biotechnol"},{"issue":"23","key":"3616_CR34","doi-asserted-by":"publisher","first-page":"23889","DOI":"10.1021\/acsomega.5c00549","volume":"10","author":"FJN Ferreira","year":"2025","unstructured":"Ferreira FJN, Carneiro AS. AI-driven drug discovery: A comprehensive review. ACS Omega. 2025;10(23):23889\u2013903.","journal-title":"ACS Omega"},{"issue":"6","key":"3616_CR35","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1038\/s41570-022-00391-9","volume":"6","author":"A Bender","year":"2022","unstructured":"Bender A, Schneider N, Segler M, et al. Evaluation guidelines for machine learning tools in the chemical sciences. Nat Rev Chem. 2022;6(6):428\u201342.","journal-title":"Nat Rev Chem"},{"issue":"10","key":"3616_CR36","doi-asserted-by":"publisher","first-page":"1713","DOI":"10.1038\/s42256-025-01124-5","volume":"7","author":"D Graber","year":"2025","unstructured":"Graber D, Stockinger P, Meyer F, et al. Resolving data bias improves generalization in binding affinity prediction. Nat Mach Intell. 2025;7(10):1713\u201325.","journal-title":"Nat Mach Intell"},{"issue":"20","key":"3616_CR37","doi-asserted-by":"publisher","first-page":"10037","DOI":"10.3390\/ijms262010037","volume":"26","author":"Q Wang","year":"2025","unstructured":"Wang Q, Sun B, Yi Y, et al. Progress of AI-Driven drug\u2013target interaction prediction and lead optimization. Int J Mol Sci. 2025;26(20):10037.","journal-title":"Int J Mol Sci"},{"issue":"6","key":"3616_CR38","doi-asserted-by":"publisher","first-page":"891","DOI":"10.3390\/ph16060891","volume":"16","author":"A Blanco-Gonz\u00e1lez","year":"2023","unstructured":"Blanco-Gonz\u00e1lez A, Cabez\u00f3n A, Seco-Gonz\u00e1lez A, et al. The role of AI in drug discovery: Challenges, opportunities, and strategies. Pharmaceuticals. 2023;16(6):891.","journal-title":"Pharmaceuticals"},{"key":"3616_CR39","doi-asserted-by":"publisher","first-page":"248","DOI":"10.3390\/medsci14020248","volume":"14","author":"G Demyashkin","year":"2026","unstructured":"Demyashkin G, Parshenkov M, Zyryanov S, et al. Artificial intelligence across the drug development lifecycle. Med Sci. 2026;14:248.","journal-title":"Med Sci"},{"issue":"2","key":"3616_CR40","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1038\/s41587-020-0418-2","volume":"38","author":"WP Walters","year":"2020","unstructured":"Walters WP, Murcko MA. Assessing the impact of generative AI on medicinal chemistry. Nat Biotechnol. 2020;38(2):143\u20135.","journal-title":"Nat Biotechnol"},{"key":"3616_CR41","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1038\/s41589-024-01679-1","volume":"20","author":"DB Catacutan","year":"2024","unstructured":"Catacutan DB, Alexander J, Arnold A, et al. Machine learning in preclinical drug discovery. Nat Chem Biol. 2024;20:960\u201373.","journal-title":"Nat Chem Biol"},{"key":"3616_CR42","doi-asserted-by":"publisher","first-page":"e70281","DOI":"10.1002\/ddr.70281","volume":"87","author":"MS Ali","year":"2026","unstructured":"Ali MS, Alqahtani T, Shmrany HA, et al. Artificial intelligence in drug discovery and development: transforming pharmaceutical innovation. Drug Dev Res. 2026;87:e70281.","journal-title":"Drug Dev Res"},{"key":"3616_CR43","doi-asserted-by":"publisher","first-page":"1493","DOI":"10.1007\/s10844-024-00901-9","volume":"62","author":"D Malerba","year":"2024","unstructured":"Malerba D, Pasquadibisceglie V, Data-Centric AI. J Intell Inf Syst. 2024;62:1493\u2013502.","journal-title":"J Intell Inf Syst"},{"issue":"2","key":"3616_CR44","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1039\/C7SC02664A","volume":"9","author":"Z Wu","year":"2017","unstructured":"Wu Z, Ramsundar B, Feinberg EN, et al. MoleculeNet: A benchmark for molecular machine learning. Chem Sci. 2017;9(2):513\u201330.","journal-title":"Chem Sci"},{"issue":"9","key":"3616_CR45","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.3390\/pharmaceutics17091119","volume":"17","author":"YA Qadri","year":"2025","unstructured":"Qadri YA, Shaikh S, Ahmad K, et al. Explainable artificial intelligence: A perspective on drug discovery. Pharmaceutics. 2025;17(9):1119.","journal-title":"Pharmaceutics"},{"issue":"3","key":"3616_CR46","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1038\/nrd3368","volume":"10","author":"RR Macarron","year":"2011","unstructured":"Macarron RR, Banks MN, Bojanic D, et al. Impact of high-throughput screening in biomedical research. Nat Rev Drug Discov. 2011;10(3):188\u201395.","journal-title":"Nat Rev Drug Discov"},{"issue":"2","key":"3616_CR47","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1016\/j.drudis.2020.12.009","volume":"26","author":"A Bender","year":"2021","unstructured":"Bender A, Cort\u00e9s-Ciriano I. Artificial intelligence in drug discovery: what is realistic, what are illusions? Part 1: Ways to make an impact, and why we are not there yet. Drug Discov Today. 2021;26(2):511\u201324.","journal-title":"Drug Discov Today"},{"issue":"13","key":"3616_CR48","doi-asserted-by":"publisher","first-page":"8736","DOI":"10.1021\/acs.chemrev.3c00189","volume":"123","author":"B Dou","year":"2023","unstructured":"Dou B, Zhu Z, Merkurjev E, et al. Machine learning methods for small data challenges in molecular science. Chem Rev. 2023;123(13):8736\u201380.","journal-title":"Chem Rev"},{"issue":"10","key":"3616_CR49","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1038\/s41589-022-01131-2","volume":"18","author":"K Huang","year":"2022","unstructured":"Huang K, Fu T, Gao W, et al. Artificial intelligence foundation for therapeutic science. Nat Chem Biol. 2022;18(10):1033\u20136.","journal-title":"Nat Chem Biol"},{"issue":"8","key":"3616_CR50","doi-asserted-by":"publisher","first-page":"3770","DOI":"10.1021\/acs.jcim.0c00502","volume":"60","author":"L Hirschfeld","year":"2020","unstructured":"Hirschfeld L, Swanson K, Yang K, et al. Uncertainty quantification using neural networks for molecular property prediction. J Chem Inf Model. 2020;60(8):3770\u201380.","journal-title":"J Chem Inf Model"},{"issue":"4","key":"3616_CR51","doi-asserted-by":"publisher","first-page":"1040","DOI":"10.1016\/j.drudis.2020.11.037","volume":"26","author":"A Bender","year":"2021","unstructured":"Bender A, Cort\u00e9s-Ciriano I. Artificial intelligence in drug discovery: what is realistic, what are illusions? Part 2: A discussion of chemical and biological data. Drug Discov Today. 2021;26(4):1040\u201352.","journal-title":"Drug Discov Today"},{"issue":"6","key":"3616_CR52","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1111\/j.1476-5381.2010.01127.x","volume":"162","author":"JP Hughes","year":"2011","unstructured":"Hughes JP, Rees S, Kalindjian SB, et al. Principles of early drug discovery. Br J Pharmacol. 2011;162(6):1239\u201349.","journal-title":"Br J Pharmacol"},{"key":"3616_CR53","doi-asserted-by":"publisher","first-page":"4288","DOI":"10.1016\/j.csbj.2022.07.049","volume":"20","author":"S Lim","year":"2022","unstructured":"Lim S, Lee S, Piao Y, et al. On modeling and utilizing chemical compound information with deep learning technologies: A task-oriented approach. Comput Struct Biotechnol J. 2022;20:4288\u2013304.","journal-title":"Comput Struct Biotechnol J"},{"key":"3616_CR54","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.inffus.2019.12.012","volume":"58","author":"A Barredo Arrieta","year":"2020","unstructured":"Barredo Arrieta A, D\u00edaz-Rodr\u00edguez N, Ser JD, et al. Explainable artificial intelligence (XAI): Concepts, taxonomies, opportunities and challenges toward responsible AI. Inf Fusion. 2020;58:82\u2013115.","journal-title":"Inf Fusion"},{"issue":"5","key":"3616_CR55","doi-asserted-by":"publisher","first-page":"916","DOI":"10.1021\/acs.jcim.7b00403","volume":"58","author":"I Wallach","year":"2018","unstructured":"Wallach I, Heifets A. Most ligand-based classification benchmarks reward memorization rather than generalization. J Chem Inf Model. 2018;58(5):916\u201332.","journal-title":"J Chem Inf Model"},{"issue":"6377","key":"3616_CR56","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1126\/science.359.6377.725","volume":"359","author":"M Hutson","year":"2018","unstructured":"Hutson M. Artificial intelligence faces reproducibility crisis. Science. 2018;359(6377):725\u20136.","journal-title":"Science"},{"key":"3616_CR57","doi-asserted-by":"publisher","first-page":"D930","DOI":"10.1093\/nar\/gky1075","volume":"47D1","author":"D Mendez","year":"2019","unstructured":"Mendez D, Gaulton A, Bento AP, et al. ChEMBL: Towards direct deposition of bioassay data. Nucleic Acids Res. 2019;47D1:D930\u201340.","journal-title":"Nucleic Acids Res"},{"issue":"3","key":"3616_CR58","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1056\/NEJMc2104626","volume":"385","author":"SG Finlayson","year":"2021","unstructured":"Finlayson SG, Subbaswamy A, Singh K, et al. The clinician and dataset shift in artificial intelligence. N Engl J Med. 2021;385(3):283\u20136.","journal-title":"N Engl J Med"},{"key":"3616_CR59","doi-asserted-by":"publisher","first-page":"160018","DOI":"10.1038\/sdata.2016.18","volume":"3","author":"MD Wilkinson","year":"2016","unstructured":"Wilkinson MD, Dumontier M, Aalbersberg IJ, et al. The FAIR guiding principles for scientific data management and stewardship. Sci Data. 2016;3:160018.","journal-title":"Sci Data"},{"issue":"5","key":"3616_CR60","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1038\/s41573-019-0050-3","volume":"19","author":"P Schneider","year":"2020","unstructured":"Schneider P, Walters WP, Plowright AT, et al. Rethinking drug design in the artificial intelligence era. Nat Rev Drug Discov. 2020;19(5):353\u201364.","journal-title":"Nat Rev Drug Discov"},{"issue":"40","key":"3616_CR61","doi-asserted-by":"publisher","first-page":"e03968","DOI":"10.1002\/slct.202503968","volume":"10","author":"AMK El-sagheir","year":"2025","unstructured":"El-sagheir AMK, Mohamed FAAA, Mohamed MFS. Targeting OGG1 for pulmonary fibrosis: An integrated in silico study with quantum chemical calculations, docking, pharmacophore modeling, molecular dynamics, and ADMET evaluation. ChemistrySelect. 2025;10(40):e03968.","journal-title":"ChemistrySelect"},{"issue":"9","key":"3616_CR62","doi-asserted-by":"publisher","first-page":"3782","DOI":"10.1021\/acs.jcim.9b00367","volume":"59","author":"KD Konze","year":"2019","unstructured":"Konze KD, Bos PH, Dahlgren MK, et al. Reaction-based enumeration, active learning, and free energy calculations to rapidly explore synthetically tractable chemical space and optimize potency of cyclin-dependent kinase 2 inhibitors. J Chem Inf Model. 2019;59(9):3782\u201393.","journal-title":"J Chem Inf Model"},{"issue":"7","key":"3616_CR63","doi-asserted-by":"publisher","first-page":"e1005690","DOI":"10.1371\/journal.pcbi.1005690","volume":"13","author":"Z Cang","year":"2017","unstructured":"Cang Z, Wei GW. TopologyNet: Topology based deep convolutional and multi-task neural networks for biomolecular property predictions. PLoS Comput Biol. 2017;13(7):e1005690.","journal-title":"PLoS Comput Biol"},{"key":"3616_CR64","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1007\/978-1-0716-3441-7_7","volume":"2714","author":"S AlRawashdeh","year":"2024","unstructured":"AlRawashdeh S, Barakat KH. Applications of molecular dynamics simulations in drug discovery. Methods Mol Biol. 2024;2714:127\u201341.","journal-title":"Methods Mol Biol"},{"issue":"10","key":"3616_CR65","doi-asserted-by":"publisher","first-page":"1328","DOI":"10.3390\/pharmaceutics16101328","volume":"16","author":"DR Serrano","year":"2024","unstructured":"Serrano DR, Luciano FC, Anaya BJ, et al. Artificial intelligence (AI) applications in drug discovery and drug delivery: Revolutionizing personalized medicine. Pharmaceutics. 2024;16(10):1328.","journal-title":"Pharmaceutics"},{"issue":"7815","key":"3616_CR66","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1038\/s41586-020-2442-2","volume":"583","author":"B Burger","year":"2020","unstructured":"Burger B, Maffettone PM, Gusev VV, et al. A mobile robotic chemist. Nature. 2020;583(7815):237\u201341.","journal-title":"Nature"},{"issue":"8122","key":"3616_CR67","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1038\/s41586-026-10652-y","volume":"655","author":"AE Ghareeb","year":"2026","unstructured":"Ghareeb AE, Chang B, Mitchener L, et al. A multi-agent system for automating scientific discovery. Nature. 2026;655(8122):497\u2013505.","journal-title":"Nature"},{"issue":"7992","key":"3616_CR68","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1038\/s41586-023-06792-0","volume":"624","author":"DA Boiko","year":"2023","unstructured":"Boiko DA, MacKnight R, Kline B, et al. Autonomous chemical research with large language models. Nature. 2023;624(7992):570\u20138.","journal-title":"Nature"},{"key":"3616_CR69","doi-asserted-by":"publisher","first-page":"1622292","DOI":"10.3389\/frai.2025.1622292","volume":"8","author":"D Anh-Hoang","year":"2025","unstructured":"Anh-Hoang D, Tran V, Nguyen LM. Survey and analysis of hallucinations in large language models: attribution to prompting strategies or model behavior. Front Artif Intell. 2025;8:1622292.","journal-title":"Front Artif Intell"},{"issue":"6","key":"3616_CR70","doi-asserted-by":"publisher","first-page":"901","DOI":"10.3390\/ph18060901","volume":"18","author":"SK Niazi","year":"2025","unstructured":"Niazi SK. Regulatory perspectives for AI\/ML implementation in pharmaceutical GMP environments. Pharmaceuticals. 2025;18(6):901.","journal-title":"Pharmaceuticals"},{"issue":"1","key":"3616_CR71","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1002\/cpt.70300","volume":"120","author":"LM Nollen","year":"2026","unstructured":"Nollen LM, van Westen GJP, Westman G, et al. Artificial intelligence for regulatory evidence: A systematic document analysis of European medicines agency regulatory advice and public reports. Clin Pharmacol Ther. 2026;120(1):224\u201335.","journal-title":"Clin Pharmacol Ther"},{"key":"3616_CR72","unstructured":"Food US, and Drug Administration (FDA). Guiding principles of good AI practice in drug development. Silver Spring (MD): U.S. FoodDrug Administration; 2026. Available from: FDA Guiding Principles of Good AI Practice in Drug Development."},{"key":"3616_CR73","volume-title":"Reflection paper on the use of Artificial Intelligence (AI) in the medicinal product lifecycle. EMA\/CHMP\/CVMP\/83833\/2023","author":"European Medicines Agency (EMA)","year":"2024","unstructured":"European Medicines Agency (EMA). Reflection paper on the use of Artificial Intelligence (AI) in the medicinal product lifecycle. EMA\/CHMP\/CVMP\/83833\/2023. Amsterdam: European Medicines Agency; 2024. Available from: EMA Scientific Guideline."},{"issue":"5","key":"3616_CR74","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1038\/s42256-024-00832-8","volume":"6","author":"AM Bran","year":"2024","unstructured":"Bran AM, Cox S, Schilter O, et al. Augmenting large language models with chemistry tools. Nat Mach Intell. 2024;6(5):525\u201335.","journal-title":"Nat Mach Intell"},{"issue":"10","key":"3616_CR75","doi-asserted-by":"publisher","first-page":"4311","DOI":"10.1021\/acs.molpharmaceut.8b00930","volume":"15","author":"A Zhavoronkov","year":"2018","unstructured":"Zhavoronkov A. Artificial intelligence for drug discovery, biomarker development, and generation of novel chemistry. Mol Pharm. 2018;15(10):4311\u20133.","journal-title":"Mol Pharm"},{"issue":"4","key":"3616_CR76","doi-asserted-by":"publisher","first-page":"1499","DOI":"10.1021\/jacsau.4c01160","volume":"5","author":"J Choi","year":"2025","unstructured":"Choi J, Nam G, Choi J, et al. A perspective on foundation models in chemistry. JACS Au. 2025;5(4):1499\u2013518.","journal-title":"JACS Au"},{"issue":"3","key":"3616_CR77","doi-asserted-by":"publisher","first-page":"104655","DOI":"10.1016\/j.drudis.2026.104655","volume":"31","author":"Y Ghanwatkar","year":"2026","unstructured":"Ghanwatkar Y, Rajdeo P, Mahato RI. Foundation models and AI agents in oncology drug discovery. Drug Discov Today. 2026;31(3):104655.","journal-title":"Drug Discov Today"},{"issue":"12","key":"3616_CR78","doi-asserted-by":"publisher","first-page":"1493","DOI":"10.1080\/17460441.2025.2601102","volume":"20","author":"AR Bradley","year":"2025","unstructured":"Bradley AR, Rossall A, Pairaudeau G, et al. From algorithms to systems: Integrating computation into drug discovery. Expert Opin Drug Discov. 2025;20(12):1493\u2013503.","journal-title":"Expert Opin Drug Discov"},{"issue":"8059","key":"3616_CR79","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1038\/s41586-025-08710-y","volume":"640","author":"H Cui","year":"2025","unstructured":"Cui H, Tejada-Lapuerta A, Brbi\u0107 M, et al. Towards multimodal foundation models in molecular cell biology. Nature. 2025;640(8059):623\u201333.","journal-title":"Nature"},{"issue":"9","key":"3616_CR80","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.3390\/ph18091271","volume":"18","author":"SK Niazi","year":"2025","unstructured":"Niazi SK. Artificial intelligence in small-molecule drug discovery: A critical review of methods, applications, and real-world outcomes. Pharmaceuticals. 2025;18(9):1271.","journal-title":"Pharmaceuticals"},{"issue":"3","key":"3616_CR81","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1016\/j.trechm.2019.02.007","volume":"1","author":"F H\u00e4se","year":"2019","unstructured":"H\u00e4se F, Roch LM, Aspuru-Guzik A. Next-generation experimentation with self-driving laboratories. Trends Chem. 2019;1(3):282\u201391.","journal-title":"Trends Chem"},{"key":"3616_CR82","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1146\/annurev-pharmtox-040323-040828","volume":"64","author":"C Hasselgren","year":"2024","unstructured":"Hasselgren C. Oprea. Artificial intelligence for drug discovery: Are we there yet? Annu Rev Pharmacol Toxicol. 2024;64:527\u201350.","journal-title":"Annu Rev Pharmacol Toxicol"},{"issue":"3","key":"3616_CR83","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1038\/d41573-024-00036-0","volume":"23","author":"A Mullard","year":"2024","unstructured":"Mullard A. When can AI deliver the drug discovery hits? Nat Rev Drug Discov. 2024;23(3):159\u201361.","journal-title":"Nat Rev Drug Discov"}],"container-title":["Medicinal Chemistry Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00044-026-03616-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00044-026-03616-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00044-026-03616-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T17:02:21Z","timestamp":1789664541000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00044-026-03616-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,17]]},"references-count":83,"alternative-id":["3616"],"URL":"https:\/\/doi.org\/10.1007\/s00044-026-03616-4","relation":{},"ISSN":["1054-2523","1554-8120"],"issn-type":[{"value":"1054-2523","type":"print"},{"value":"1554-8120","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,17]]},"assertion":[{"value":"26 July 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interest.","order":1,"name":"Ethics","label":"Conflict of interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}